Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition.
Saved in:
| Title: | Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition. |
|---|---|
| Authors: | Gil Del Alcazar CR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Huh SJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Ekram MB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Trinh A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Liu LL; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Beca F; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Zi X; Department of Biomedical Engineering, Yale University, New Haven, Connecticut.; Second Military Medical University, Shanghai, P.R. China., Kwak M; Department of Biomedical Engineering, Yale University, New Haven, Connecticut., Bergholtz H; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Su Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Ding L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Russnes HG; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Richardson AL; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Pathology, Harvard Medical School, Boston, Massachusetts., Babski K; Sutter Roseville Medical Center, Roseville, California., Min Hui Kim E; Sutter Roseville Medical Center, Roseville, California., McDonnell CH 3rd; Sutter Roseville Medical Center, Roseville, California., Wagner J; Sutter Roseville Medical Center, Roseville, California., Rowberry R; Sutter Roseville Medical Center, Roseville, California., Freeman GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Dillon D; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Pathology, Harvard Medical School, Boston, Massachusetts., Sorlie T; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Coussens LM; Department of Cell, Developmental & Cancer Biology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon., Garber JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Fan R; Department of Biomedical Engineering, Yale University, New Haven, Connecticut., Bobolis K; Sutter Roseville Medical Center, Roseville, California., Allred DC; Department of Pathology, Washington University School of Medicine, St. Louis, Missouri., Jeong J; Department of Surgery, Gangnam Severance Hospital, Yonsei University Medical College, Seoul, Korea., Park SY; Department of Pathology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea., Michor F; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Polyak K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. kornelia_polyak@dfci.harvard.edu.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; The Broad Institute, Cambridge, Massachusetts.; Harvard Stem Cell Institute, Cambridge, Massachusetts. |
| Source: | Cancer discovery [Cancer Discov] 2017 Oct; Vol. 7 (10), pp. 1098-1115. Date of Electronic Publication: 2017 Jun 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 28652380 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gil+Del+Alcazar+CR%22">Gil Del Alcazar CR</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Huh+SJ%22">Huh SJ</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Ekram+MB%22">Ekram MB</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Trinh+A%22">Trinh A</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Liu+LL%22">Liu LL</searchLink>; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Beca+F%22">Beca F</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Zi+X%22">Zi X</searchLink>; Department of Biomedical Engineering, Yale University, New Haven, Connecticut.; Second Military Medical University, Shanghai, P.R. China.<br /><searchLink fieldCode="AU" term="%22Kwak+M%22">Kwak M</searchLink>; Department of Biomedical Engineering, Yale University, New Haven, Connecticut.<br /><searchLink fieldCode="AU" term="%22Bergholtz+H%22">Bergholtz H</searchLink>; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Su+Y%22">Su Y</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Ding+L%22">Ding L</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Russnes+HG%22">Russnes HG</searchLink>; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Richardson+AL%22">Richardson AL</searchLink>; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Pathology, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Babski+K%22">Babski K</searchLink>; Sutter Roseville Medical Center, Roseville, California.<br /><searchLink fieldCode="AU" term="%22Min+Hui+Kim+E%22">Min Hui Kim E</searchLink>; Sutter Roseville Medical Center, Roseville, California.<br /><searchLink fieldCode="AU" term="%22McDonnell+CH+3rd%22">McDonnell CH 3rd</searchLink>; Sutter Roseville Medical Center, Roseville, California.<br /><searchLink fieldCode="AU" term="%22Wagner+J%22">Wagner J</searchLink>; Sutter Roseville Medical Center, Roseville, California.<br /><searchLink fieldCode="AU" term="%22Rowberry+R%22">Rowberry R</searchLink>; Sutter Roseville Medical Center, Roseville, California.<br /><searchLink fieldCode="AU" term="%22Freeman+GJ%22">Freeman GJ</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Dillon+D%22">Dillon D</searchLink>; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Pathology, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Sorlie+T%22">Sorlie T</searchLink>; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Coussens+LM%22">Coussens LM</searchLink>; Department of Cell, Developmental & Cancer Biology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.<br /><searchLink fieldCode="AU" term="%22Garber+JE%22">Garber JE</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Fan+R%22">Fan R</searchLink>; Department of Biomedical Engineering, Yale University, New Haven, Connecticut.<br /><searchLink fieldCode="AU" term="%22Bobolis+K%22">Bobolis K</searchLink>; Sutter Roseville Medical Center, Roseville, California.<br /><searchLink fieldCode="AU" term="%22Allred+DC%22">Allred DC</searchLink>; Department of Pathology, Washington University School of Medicine, St. Louis, Missouri.<br /><searchLink fieldCode="AU" term="%22Jeong+J%22">Jeong J</searchLink>; Department of Surgery, Gangnam Severance Hospital, Yonsei University Medical College, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Park+SY%22">Park SY</searchLink>; Department of Pathology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.<br /><searchLink fieldCode="AU" term="%22Michor+F%22">Michor F</searchLink>; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Polyak+K%22">Polyak K</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. kornelia&#95;polyak@dfci.harvard.edu.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; The Broad Institute, Cambridge, Massachusetts.; Harvard Stem Cell Institute, Cambridge, Massachusetts. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101561693%22">Cancer discovery</searchLink> [Cancer Discov] 2017 Oct; Vol. 7 (10), pp. 1098-1115. <i>Date of Electronic Publication: </i>2017 Jun 26. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101561693 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2159-8290 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221598274%22">21598274 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Discov <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28652380 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/2159-8290.CD-17-0222 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1098 Titles: – TitleFull: Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gil Del Alcazar CR – PersonEntity: Name: NameFull: Huh SJ – PersonEntity: Name: NameFull: Ekram MB – PersonEntity: Name: NameFull: Trinh A – PersonEntity: Name: NameFull: Liu LL – PersonEntity: Name: NameFull: Beca F – PersonEntity: Name: NameFull: Zi X – PersonEntity: Name: NameFull: Kwak M – PersonEntity: Name: NameFull: Bergholtz H – PersonEntity: Name: NameFull: Su Y – PersonEntity: Name: NameFull: Ding L – PersonEntity: Name: NameFull: Russnes HG – PersonEntity: Name: NameFull: Richardson AL – PersonEntity: Name: NameFull: Babski K – PersonEntity: Name: NameFull: Min Hui Kim E – PersonEntity: Name: NameFull: McDonnell CH 3rd – PersonEntity: Name: NameFull: Wagner J – PersonEntity: Name: NameFull: Rowberry R – PersonEntity: Name: NameFull: Freeman GJ – PersonEntity: Name: NameFull: Dillon D – PersonEntity: Name: NameFull: Sorlie T – PersonEntity: Name: NameFull: Coussens LM – PersonEntity: Name: NameFull: Garber JE – PersonEntity: Name: NameFull: Fan R – PersonEntity: Name: NameFull: Bobolis K – PersonEntity: Name: NameFull: Allred DC – PersonEntity: Name: NameFull: Jeong J – PersonEntity: Name: NameFull: Park SY – PersonEntity: Name: NameFull: Michor F – PersonEntity: Name: NameFull: Polyak K IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2017 Oct Type: published Y: 2017 Identifiers: – Type: issn-electronic Value: 2159-8290 Numbering: – Type: volume Value: 7 – Type: issue Value: 10 Titles: – TitleFull: Cancer discovery Type: main |
| ResultId | 1 |